表紙
市場調查報告書

預填充式注射器的全球市場:2019年∼2029年

Global Pre-Filled Syringes Market Forecast 2019-2029: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes, Pen Injectors and Autoinjectors, Insulin Therapies, Rheumatoid Arthritis (RA) Therapies, Growth Hormones, Vaccines, PCSK9 Inhibitors

出版商 Visiongain Ltd 商品編碼 206673
出版日期 內容資訊 英文 274 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
預填充式注射器的全球市場:2019年∼2029年 Global Pre-Filled Syringes Market Forecast 2019-2029: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes, Pen Injectors and Autoinjectors, Insulin Therapies, Rheumatoid Arthritis (RA) Therapies, Growth Hormones, Vaccines, PCSK9 Inhibitors
出版日期: 2019年01月31日內容資訊: 英文 274 Pages
簡介

全球預填充式注射器市場,2018年達到了98億美元。市場,預計2019年∼2024年以 12.9%的年複合成長率成長。

本報告提供全球預填充式注射器市場相關調查分析,市場概要,市場動態,市場預測,各地區預測,主要企業等相關的系統性資訊。

第1章 報告概要

第2章 預填充式注射器市場簡介

  • 所謂預填充式注射器
  • 簡歷
  • 設計和生產
  • 所謂筆注射器、自動注射器
  • 玻璃製 vs. 塑膠製
  • 未來的方向性
  • 市場區隔
  • 調查範圍
  • 匯率

第3章 預填充式注射器:全球市場

  • 全球藥物輸送市場佔有率
  • 全球市場
  • 銷售額預測:各金額
  • 市場佔有率的變化
  • 促進因素與阻礙因素
  • 未來趨勢
  • 玻璃製預填充式注射器
  • 塑膠製預填充式注射器
  • 筆注射器、自動注射器

第4章 主要國家、各地區市場

  • 主要國家的明細
  • 各國市場預測
  • 地區的明細
  • 各地區市場的預測
  • 美國
  • 日本
  • EU5個國家
  • 新興市場

第5章 預填充式注射器的主要治療領域

  • 主要治療領域
  • 糖尿病
  • 類風濕性關節炎
  • 生長激素
  • 疫苗
  • PCSK9抑制劑
  • 其他

第6章 預填充式設備的主要治療

  • 主要胰島素療法 (筆注射器)
  • 主要生物製劑 (生技藥品)
  • 生長激素
  • 主要PCSK9產品

第7章 預填充式注射器、相關技術的主要製造商

  • 主要廠商的市場佔有率
    • Becton, Dickinson & Company
    • Gerresheimer
    • Schott
  • 其他值得注意的主要製造商
  • 筆注射器、自動注射器主要製造商
    • SHL Group
    • Ypsomed
    • Haselmeier
    • Owen Mumford
    • Bespak
    • 其他
  • 預填充式注射器零組件主要製造商

第8章 預填充式注射器市場定性分析

  • SWOT分析
  • STEP分析
  • 法規和安全性預測
  • 生物製劑 (生技藥品) 和預填充式注射器市場
  • 預填充式注射器產業的發展與成長中患者所扮演的角色
  • 預填充式注射器的技術開發
  • 預填充式注射器產業的外包

第9章 結論

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0353

The global pre-filled syringes market was valued at $9.8bn in 2018. This market is estimated to grow at a CAGR of 12.9% in the first half of the forecast period. In 2018, the glass pre-filled syringes submarket held 53% of the global pre-filled syringes.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report, you will find 274-page report and you will receive 101 tables and 86 figures - all unavailable elsewhere.

The 274-page report provides clear detailed insight into the global pre-filled syringes market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

  • Global Pre-Filled Syringes market forecasts from 2019-2029
  • Pre-Filled Syringes submarket forecasts by type from 2019-2029 covering:
    • Glass Pre-Filled Syringes
    • Pen Injectors and Autoinjectors
    • Plastic Pre-Filled Syringes
  • Forecasts from 2019-2029 of the leading therapeutic sectors for the Pre-Filled Syringes market:
    • Insulin Therapies
    • Rheumatoid Arthritis (RA) Therapies
    • Growth Hormones
    • Vaccines
    • PCSK9 Inhibitors
  • Pre-Filled Syringes national market forecasts from 2019-2029, covering:
    • United States
    • Japan
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Brazil
    • Russia
    • India
    • China

image1

Each national market is further segmented by type and application.

  • Forecasts from 2019-2029 of selected leading products:
    • Enbrel
    • Genotropin
    • Humalog
    • Humira
    • Humulin
    • Lantus
    • Levemir
    • Norditropin
    • NovoMix
    • NovoRapid/Novolog
    • Praluent
    • Repatha
    • Rituxan
    • Toujeo
    • Trulicity
  • Assessment of the leading pre-filled syringes manufacturers and related technology manufacturers.
  • SWOT and STEP analysis of the global pre-filled syringes market.

Visiongain's study is intended for anyone requiring commercial analyses for the Pre-Filled Syringes Market and leading companies. You find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1. Global Pre-Filled Syringes Market Overview
  • 1.2. Global Pre-Filled Syringes Market Segmentation
  • 1.3. Why You Should Read This Report
  • 1.4. How This Report Delivers
  • 1.5. Key Questions Answered by This Analytical Report
  • 1.6. Who is This Report For?
  • 1.7. Methodology
  • 1.8. Frequently Asked Questions (FAQ)
  • 1.9. Associated Visiongain Reports
  • 1.10. About Visiongain

2. Introduction to Pre-Filled Syringes

  • 2.1. What are Pre-Filled Syringes?
  • 2.2. A Brief History of Pre-Filled Syringes
  • 2.3. Design and Manufacture of Pre-Filled Syringes
    • 2.3.1. Glass and Plastic Syringes
    • 2.3.2. Safety and the Pre-Filled Syringe Market
    • 2.3.3. Concerns over Needlestick Injuries
  • 2.4. An Introduction to Pen Injectors and Autoinjectors
    • 2.4.1. Pen Injectors and Autoinjectors Offer Advantages in Self-Administration
    • 2.4.2. What Determines Injection Device Choice?
  • 2.5. Glass versus Plastic
    • 2.5.1. Glass
    • 2.5.2. Plastic
  • 2.6. Future Directions for Pre-Filled Syringes
  • 2.7. Pre-Filled Syringes: Market Segmentation
  • 2.8. Scope of this Report
  • 2.8.1. Products Excluded from this Report
  • 2.9. Currency Exchange Rates in This Report

3. Pre-Filled Syringes: World Market 2019-2029

  • 3.1. Pre-Filled Syringes as a Share of the Global Drug Delivery Market
  • 3.2. The World Pre-Filled Syringes Market in 2018
    • 3.2.1. World Pre-Filled Syringes Market: Market Shares by Segment 2018
    • 3.2.2. Leading Companies in the Pre-Filled Syringes Market
    • 3.2.3. Market Genericisation and Pre-Filled Syringes
  • 3.3. World Pre-Filled Syringes Market: Sales Forecast by Value, 2019-2029
  • 3.4. How Will Segmental Market Shares Change to 2029?
  • 3.5. World Pre-Filled Syringes Market: Drivers and Restraints 2018-2029
    • 3.5.1. Innovation and Targeted New Molecules to Drive Market Growth
    • 3.5.2. Human Factors and Regulatory Requirements
    • 3.5.3. Advances in Pre-Filled Syringe Manufacturing
    • 3.5.4. The Injectable Drug Pipeline is Substantial
    • 3.5.5. Competing Drug Delivery Technologies
    • 3.5.6. Complex Molecules Sensitivity and Packaging
    • 3.5.7. Necessity of Improved Connected Devices Technology
  • 3.6. World Pre-Filled Syringes Market: Future Trends 2018-2029
    • 3.6.1. Automation and Inspection to meet high quality standards
    • 3.6.2. Shift from Hospital Care to Home Care
  • 3.7. Glass Pre-Filled Syringes Lead the Pre-Filled Syringes Market
    • 3.7.1. Glass Pre-Filled Syringes Market: Sales Forecast by Value, 2018-2029
    • 3.7.2. Glass Pre-Filled Syringes: Drivers and Restraints 2018-2029
  • 3.8. Plastic Pre-Filled Syringes: Rapid Growth Forecasted
    • 3.8.1. Plastic Pre-Filled Syringes Market: Sales Forecast by Revenue, 2018-2029
    • 3.8.2. Plastic Pre-Filled Syringes: Drivers and Restraints 2018-2029
  • 3.9. Pen Injectors and Autoinjectors: A Growing Segment
    • 3.9.1. Pen Injectors and Autoinjectors Market: Sales Forecast by Value, 2018-2029
    • 3.9.2. Pen Injectors and Autoinjectors: Drivers and Restraints 2018-2029
    • 3.9.3. Insulin and Other Biologics to Lead Market Growth

4. Leading National and Regional Markets 2019-2029

  • 4.1. National Breakdown of the World Pre-Filled Syringes Market
  • 4.2. World Pre-Filled Syringes Market: National Markets Forecast 2019-2029
    • 4.2.1. How Will National Market Shares Change to 2029?
  • 4.3. Regional Breakdown of the World Pre-Filled Syringes Market
  • 4.4. World Pre-Filled Syringes Market: Regional Markets Forecast 2019-2029
    • 4.4.1. How Will Regional Market Shares Change to 2029?
  • 4.5. US Pre-Filled Syringes Market Forecast 2018-2029
    • 4.5.1. US Pre-Filled Syringes Market: Trends and Developments
    • 4.5.1.1. New Drug and Device Launches to Drive Growth to 2029
    • 4.5.1.2. The Budget Control Act 2011 and the Medical Excise Tax
  • 4.6. Japanese Pre-Filled Syringes Market Forecast 2019-2029
  • 4.7. EU5 Pre-Filled Syringes Market Forecast 2019-2029
  • 4.8. Emerging Markets: Pre-Filled Syringes Market Forecast 2019-2029
    • 4.8.1. Pre-Filled Syringe Manufacturers Are Investing in Emerging Markets
    • 4.8.2. Chinese Pre-Filled Syringes Market Forecast 2019-2029
    • 4.8.3. Indian Pre-Filled Syringes Market Forecast 2019-2029
    • 4.8.4. Russian Pre-Filled Syringes Market Forecast 2019-2029
    • 4.8.5. Brazilian Pre-Filled Syringes Market Forecast 2019-2029

5. Leading Therapeutic Sectors for Pre-Filled Syringes 2018-2029

  • 5.1. Leading Therapeutic Sectors for Pre-Filled Syringes and Other Injection Devices in 2018
    • 5.1.1. Vaccines and Heparins Are Major Market Sectors
    • 5.1.2. Rising Demand in Chronic Conditions: Autoimmune Diseases and Diabetes
    • 5.1.3. Growth for Key Market Sectors 2018-2029
  • 5.2. Pre-Filled Syringes and Pen Injectors for Diabetes 2018-2029
    • 5.2.1. Insulin Market Forecast 2018-2029
    • 5.2.2. High Rates of Pen Injector Use in the EU and Japan
    • 5.2.3. Insulin Pumps: A Technology to Challenge Pen Injectors to 2029?
    • 5.2.4. MannKind's Afrezza: Inhalable Insulin Approved in US
    • 5.2.5. Injection Devices for Biosimilar Insulin Products
    • 5.2.6. Roche's Lucentis: First and Only FDA Approved Prefilled Syringe Treatment for Diabetic Retinopathy
    • 5.2.7. FDA Approves Highest Capacity Insulin Pen
  • 5.3. Rheumatoid Arthritis: Leading Biologics Dominate the Market
    • 5.3.1. Rheumatoid Arthritis Market Forecast 2018-2029
    • 5.3.2. All Major Injectable Therapies Are Marketed in Proprietary Devices
    • 5.3.3. Novel Injection Systems for RA: Meeting the Needs of Patients
    • 5.3.4. The Receding Threat from Oral Therapies to 2029
  • 5.4. Growth Hormones: Outlook to 2029
    • 5.4.1. Growth Hormones Market Forecast 2019-2029
    • 5.4.2. Biosimilar Growth Hormones and Pen Injectors
    • 5.4.3. Uptake of Needle-Free Injectors for Growth Hormones
  • 5.5. The Vaccine Market Outlook 2019-2029
    • 5.5.1. Vaccine Market Forecast 2019-2029
    • 5.5.2. Single-Use Devices for Vaccine Delivery
    • 5.5.2.1. BD Uniject: A Private-Public Collaboration
    • 5.5.3. Needle-Free Injectors for Vaccines
    • 5.5.4. Other Trends in Vaccine Delivery
  • 5.6. PCSK9 Inhibitors: The Next Advance in Cholesterol-Lowering Drugs
    • 5.6.1. PCSK9 Inhibitors Market Forecast 2019-2029
    • 5.6.2. PCSK9 Inhibitors and Pre-Filled Syringes/Injectors
  • 5.7. Others: Launch of injectables for Anaphylaxis, MS, Cancer expected to drive the Market for Prefilled Syringes

6. Leading Pre-Filled Device Therapies 2019-2029

  • 6.1. Leading Insulin Therapies Using Pen Injectors 2018-2029
    • 6.1.1. Lantus: The World's Best-Selling Insulin Analogue
      • 6.1.1.1. SoloSTAR, ClikSTAR and AllSTAR: Three Pen Injectors for Lantus
      • 6.1.1.2. Lantus: Sales Forecast 2018-2029
    • 6.1.2. NovoLog: The Leading Fast-Acting Insulin
      • 6.1.2.1. NovoLog FlexPen: To Be Retired
      • 6.1.2.2. Novo's New FlexTouch Pen Launched
      • 6.1.2.3. NovoLog: Sales Forecast 2018-2029
    • 6.1.3. Humalog
      • 6.1.3.1. Humalog: HumaPen and KwikPen
      • 6.1.3.2. Humalog: Sales Forecast 2017-2027
    • 6.1.4. Other Products in the Insulin Market
      • 6.1.4.1. Levemir
      • 6.1.4.2. Novomix
      • 6.1.4.3. Humulin
      • 6.1.4.4. Trulicity
      • 6.1.4.5. Toujeo
  • 6.2. Top Biologics for Rheumatoid Arthritis: Device Outlook to 2029
    • 6.2.1. Humira: The Biggest-Selling Drug in 2017
      • 6.2.1.1. The Humira Pen Is an Innovative Delivery Device
      • 6.2.1.2. Humira: Sales Forecast 2017-2027
      • 6.2.1.3. Humira: EU Price
    • 6.2.2. Rituxan (Rituximab): The Second Leading RA Drug
    • 6.2.3. Enbrel: The Leading Competitor to Humira
      • 6.2.3.1. Pre-Filled Injection Devices Available for Enbrel
      • 6.2.3.2. Enbrel: Sales Forecast 2019-2029
      • 6.2.3.3. Other leading RA drugs and developments
        • 6.2.3.3.1 Actemra/RoActemra (tocilizumab)
        • 6.2.3.3.2 Kevzara (sarilumab)
  • 6.3. Growth Hormones: Two Products Dominated the Market in 2018
    • 6.3.1. Norditropin: The Leading Growth Hormone
      • 6.3.1.1. Norditropin: Sales Forecast 2018-2029
    • 6.3.2. Genotropin: Sales Forecast 2019-2029
  • 6.4. Outlook for Leading PCSK9 Products 2017-2027
    • 6.4.1. Praluent (alirocumab, Sanofi/Regeneron)
      • 6.4.1.1. Praluent: Sales Forecast 2019-2029
      • 6.4.1.2. Amgen Suit Against Sanofi/Regeneron's Praluent
    • 6.4.2. Repatha (evolocumab, Amgen)
      • 6.4.2.1. Repatha: Sales Forecast 2019-2029

7. Leading Pre-Filled Syringe and Related Technology Manufacturers, 2018

  • 7.1. Leading Pre-Filled Syringe Manufacturers market share in 2017
    • 7.1.1. Becton, Dickinson & Company: The Market Leader
      • 7.1.1.1. Becton, Dickinson & Company: Pre-Filled Syringes Product Portfolio
      • 7.1.1.2. BD Historical Revenue and Market Prospects
      • 7.1.1.3. Recent Acquisitions by BD
      • 7.1.1.4. BD AutoShield Duo Pen Needle Launched in 2014
      • 7.1.1.5. BD launched first syringe that offers new delivery solution for people with insulin resistance
      • 7.1.1.6. BD launched Advanced Prefillable Syringe for Higher Volume Injection of Biologics
      • 7.1.1.7. BD launched Ultra-Fine Micro Pen Needle
    • 7.1.2. Gerresheimer
      • 7.1.2.1. Gerresheimer: Pre-Filled Syringes Product Portfolio
      • 7.1.2.2. Gerresheimer: Expansion of Product Manufacturing Facility
      • 7.1.2.3. Gerresheimer: Products in Development
      • 7.1.2.4. Patent Application for Gerresheimer's Gx Baked-On RTF
      • 7.1.2.5. Gerresheimer Commissioned to Manufacture Simponi Autoinjectors
      • 7.1.2.6. Gerresheimer Opens First Development Center in China
    • 7.1.3. Schott
      • 7.1.3.1. Schott: Pre-Filled Syringes Product Portfolio
      • 7.1.3.2. Schott Historical Revenue and Market Prospects
      • 7.1.3.3. Schott: Expansion in India
  • 7.2. Other Notable Pre-Filled Syringe Manufacturers
    • 7.2.1. Baxter: Providing Contract Manufacturing with Pre-Filled Syringes
    • 7.2.2. Nipro: Leading Japanese Contract Manufacturer
      • 7.2.2.1. Nipro's 2012 Acquisition of MGlas
    • 7.2.3. Stevanato Group/Ompi: Insulin Vials Market Leader
    • 7.2.4. Weigao: Pre-Filled Syringes for China and Beyond
    • 7.2.5. Unilife: Pre-Filled Safety Syringes
    • 7.2.6. Roselabs: Entered the Market in 2012
    • 7.2.7. Vetter Pharma: Offering Lyo-Ject Dual-Chamber Syringes
    • 7.2.8. Other Companies
  • 7.3. Leading Pen Injector and Autoinjector Manufacturers in 2015
    • 7.3.1. SHL Group
      • 7.3.1.1. SHL Group: Pen Injectors and Autoinjectors Product Portfolio
      • 7.3.1.2. SHL Group Market Prospects
    • 7.3.2. Ypsomed
      • 7.3.2.1. Ypsomed: Pen Injectors and Autoinjectors Product Portfolio
      • 7.3.2.2. Ypsomed Historical Revenue and Market Prospects
      • 7.3.2.3. Ypsomed: Recent Developments
    • 7.3.3. Haselmeier
      • 7.3.3.1. Haselmeier: Pen Injectors and Autoinjectors Product Portfolio
      • 7.3.3.2. Haselmeier: Market Prospects
    • 7.3.4. Owen Mumford
      • 7.3.4.1. Owen Mumford: Pen Injectors and Autoinjectors Product Portfolio
    • 7.3.5. Bespak: Entering the Auto-Injectors Market
    • 7.3.6. Other Leading and Emerging Autoinjector Manufacturers
  • 7.4. Leading Pre-Filled Syringe Component Manufacturers in 2017
    • 7.4.1. Datwyler
      • 7.4.1.1. Datwyler Historical Revenue and Market Prospects

8. Qualitative Analysis of the Pre-Filled Syringes Market 2019-2029

  • 8.1. SWOT Analysis of the Pre-Filled Syringes Market
  • 8.2. Strengths
    • 8.2.1. Pre-Filled Syringes and Pen/Autoinjectors are Used in Chronic Conditions
    • 8.2.2. Device Manufacturers Offer a Range of Products
    • 8.2.3. Customisation and Product Differentiation
    • 8.2.4. Effective Lifecycle Management
    • 8.2.5. Advantages associated with pre-filled syringes
  • 8.3. Weaknesses
    • 8.3.1. Patients with Needle Phobia
    • 8.3.2. Chronic Diseases May Make Pre-Filled Syringes Difficult to Use
    • 8.3.3. Risk of Extractables and Leachables
    • 8.3.4. Higher Cost and Greater Cold Chain and Storage Requirements
  • 8.4. Opportunities
    • 8.4.1. Biosimilars Represent a Growing Market
    • 8.4.2. Viscous and Large-Volume Drugs Require Novel Devices
    • 8.4.3. Technological Developments Expanding Product Portfolios
    • 8.4.4. Many Injectable Drugs in the Pipeline
    • 8.4.5. Growth in Emerging Markets
    • 8.4.6. Rising demand for Disposables
  • 8.5. Threats
    • 8.5.1. Alternative Technologies: Needle-Free and Bolus Injectors
    • 8.5.2. New Oral Therapies for Many Chronic Conditions
    • 8.5.3. Increasing Regulatory Barriers
    • 8.5.4. Cost Pressures on Healthcare Payers
  • 8.6. STEP Analysis of the Pre-Filled Syringes Market
    • 8.6.1. Social Factors: Rising Disease Incidence and Demand for At-Home Care
    • 8.6.2. Technological Developments: Improved Safety and Administration
    • 8.6.3. Economic Pressures: Pre-Filled Syringes Are Cost Efficient
    • 8.6.3.1. High Barriers to Market Entry Exist
    • 8.6.4. Political Issues: Regulatory Developments for Pre-Filled Syringes
  • 8.7. Regulatory and Safety Outlook for Pre-Filled Syringes, 2019-2029
    • 8.7.1. Needlestick Safety and Prevention
    • 8.7.2. International Regulations for Needlestick Prevention
      • 8.7.2.1. The US: The First Country to Introduce Needlestick Legislation
      • 8.7.2.2. The EU: New Rules from 2013 Onwards
      • 8.7.2.3. Needlestick Safety in Japan
      • 8.7.2.4. Legislation for Needlestick Safety in Emerging Markets
    • 8.7.3. Manufacturers Will Continue to Develop New Devices for Needlestick Prevention
      • 8.7.3.1. Ancillary versus Integrated Safety Devices
    • 8.7.4. Extractables and Leachables
      • 8.7.4.1. Companies Will Reduce Sources of Extractables and Leachables
      • 8.7.4.2. Products that Minimise Extractables and Leachables
      • 8.7.4.3. Protein Aggregation: The Challenge of Biological Drugs
      • 8.7.4.4. Regulatory Requirements for Extractables and Leachables
  • 8.8. Biologics and the Pre-Filled Syringes Market, 2019-2029
    • 8.8.1. Manufacturing Pre-Filled Syringes for Biologics: Glass versus Plastic
    • 8.8.2. Biologics Provide New Challenges for Device Manufacturers
      • 8.8.2.1. Lyophilised Drugs and Dual-Chamber Devices
    • 8.8.3. Delivery Opportunities for High Viscosity Drugs
    • 8.8.4. Are Biosimilars an Opportunity for Pre-Filled Syringe Manufacturers?
  • 8.9. The Role of Patients in Pre-Filled Syringe Industry Development and Growth
    • 8.9.1. Chronic Disease Incidence
    • 8.9.2. The Rise in At-Home Care
    • 8.9.3. Improving Patient Adherence
    • 8.9.4. Injection Devices Must be Developed for Patient Convenience: Human Factors Engineering
  • 8.10. Technological Developments in Pre-Filled Syringes to 2029
    • 8.10.1. Product Differentiation Will be Vital in Crowded Treatment Markets
    • 8.10.2. Product Customisation: Adapting Injection Devices
    • 8.10.3. Trends in Manufacturing Materials for Pre-Filled Syringes
    • 8.10.4. Competing Technologies Will Challenge Pre-Filled Syringes
      • 8.10.4.1. Will Needle-Free Devices Become a Significant Competing Technology?
      • 8.10.4.2. Patients Prefer Oral Drug Delivery
  • 8.11. Outsourcing in the Pre-Filled Syringe Industry
    • 8.11.1. Contract Medical Device Manufacturing
    • 8.11.2. Contract Filling of Pre-Filled Syringes

9. Conclusions

  • 9.1. Pre-Filled Syringes and Pen/Autoinjectors: Strong Growth Expected
  • 9.2. The World Pre-Filled Syringes Market in 2018
    • 9.2.1. Current Leading Pre-Filled Syringes Segments
    • 9.2.2. Leading Pre-Filled Syringes Companies
    • 9.2.3. Leading National and Regional Markets
  • 9.3. World Pre-Filled Syringes Market Forecast 2019-2029
  • 9.4. The Future of the Pre-Filled Syringes Market?
    • 9.4.1. Glass Syringes Will Continue to Dominate
    • 9.4.2. Innovation for Growth

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain report evaluation form

Companies Listed

  • AbbVie
  • Ache
  • Amega Biotech
  • Amgen
  • Antares Pharma
  • Aptar Stelmi
  • AstraZeneca
  • Baxter International
  • Becton, Dickinson and Company
  • Bespak
  • Biocon
  • Bioject Medical Technologies
  • Biomarin
  • Biosidus
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Cambridge Consultants
  • CareFusion Corporation
  • Celgene
  • Centocor
  • Daikyo
  • Daikyo Seiko
  • Datwyler
  • Disetronic Group
  • Dong-A
  • Dr. Reddy's
  • Eisai Pharmaceutical
  • Eli Lilly
  • Ferring
  • Gan & Lee
  • Genentech
  • GeneScience Pharmaceuticals
  • Gerresheimer
  • Gerresheimer Medical Systems
  • GlaxoSmithKline
  • Haselmeier
  • Helvoet Pharmaceutical
  • Hospira
  • Incepta Pharmaceuticals
  • Janssen Biotech
  • Johnson and Johnson
  • LG Life Sciences/Biopartners
  • Mannkind
  • Merck & Co
  • Merck Serono
  • Mitsubishi Tanabe
  • Nektar Therapeutics
  • Nipro
  • Novartis
  • Novo Nordisk
  • Ompi
  • OPKO Health
  • Oval Medical
  • Owen Mumford
  • PA Consulting Group
  • Palatin Technologies
  • Pfizer
  • PharmaJet
  • Pharmstandard
  • Polfa Tarchomin
  • Regeneron
  • Rhône Poulenc-Rorer
  • Roehr Products
  • Roselabs Bioscience
  • Samsung Bioepis
  • Sandoz
  • Sanofi
  • Schott
  • Schott Kaisha
  • Schott Xinkang Pharmaceutical Packaging
  • SciGen
  • Shanghai Celgen Bio-Pharmaceutical
  • Shanghai CP Guojin
  • SHL Group
  • Square Pharmaceuticals
  • Stevanato Group (Ompi)
  • Takeda Pharmaceutical
  • Terumo
  • Teva Pharmaceutical
  • the Stevanato Group (Ompi)
  • Tonghua Dongbao
  • UCB
  • Unilife
  • Vetter Pharma
  • Weigao
  • West Pharmaceutical Services
  • West Pharmaceuticals
  • Wockhardt
  • Ypsomed
  • Zeon

List of Organizations Mentioned in the Report

  • Battele Memorial Institute
  • Carl Zeiss Foundation
  • Centers for Disease Control (US)
  • European Society of Cardiology
  • National Health Service (UK)
  • Parenteral Drug Association
  • PATH
  • UNICEF
  • US Agency for International Development
  • US Federal Drug Administration
  • World Health Organization

List of Tables

  • Table 3.1 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by Segment, 2018-2029
  • Table 3.2 Market Shares (%) of Leading Pre-Filled Syringes Market Segments, by Revenue, 2018, 2023 and 2029
  • Table 3.3 Glass Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 3.4 Selected Proprietary Polymers for Plastic Pre-Filled Syringes, 2018
  • Table 3.5 Plastic Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 3.6 Pen Injectors and Autoinjectors Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.1 World Pre-Filled Syringes Market: Revenues ($m) and Market Shares (%) by National Market, 2018
  • Table 4.2 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by National Market, 2018-2029
  • Table 4.3 Market Shares (%) of Leading National Pre-Filled Syringes Markets, 2018, 2023 and 2029
  • Table 4.4 World Pre-Filled Syringes Market: Revenues ($m) and Market Shares (%) by Regional Market, 2018
  • Table 4.5 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by Regional Market, 2018-2029
  • Table 4.6 Market Shares of Leading Regional Pre-Filled Syringes Markets, 2018, 2023 and 2029
  • Table 4.7 US Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.8 U.S. Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.9 U.S. Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.10 Japanese Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.11 Japanese Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.12 Japanese Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.13 EU5 Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by National Market, 2018-2029
  • Table 4.14 UK Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.15 UK Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.16 Germany Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.17 Germany Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.18 France Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.19 France Pre-Filled Syringes Market Forecast, By Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.20 Italy Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.21 Italy Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.22 Spain Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.23 Spain Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.24 Chinese Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.25 Chinese Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.26 Chinese Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.27 Indian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.28 Indian Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.29 Indian Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.30 Russian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.31 Russian Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.32 Russian Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.33 Brazilian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.34 Brazilian Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 4.35 Brazilian Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 5.1 Pen Manufacturing Agreements for Leading Insulin Brand Manufacturers, 2017
  • Table 5.2 Selected Biosimilar Insulin Pen Injectors, 2017
  • Table 5.3 Insulin Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 5.4 Prefilled Syringes Application in Diabetes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 5.5 Rheumatoid Arthritis Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 5.6 Prefilled Syringes Application in Rheumatoid Arthritis Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 5.7 Growth Hormone Therapies in Pen Injectors, 2018
  • Table 5.8 Growth Hormones Market Forecast: Revenues ($m), AGR and CAGR, 2018-2029
  • Table 5.9 Selected Biosimilar Growth Hormones in Emerging Markets, 2018
  • Table 5.10 Vaccines Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 5.11 PCSK9 Inhibitors Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 5.12 Prefilled Syringes Application in Anaphylaxis Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 6.1 Leading Pre-Filled Insulin Therapies: Revenues ($m), 2015-2018
  • Table 6.2 Sanofi: Lantus Revenue ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 6.3 Novo Nordisk: NovoLog Revenue ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 6.4 Eli Lilly: Humalog Revenue ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 6.5 Novo Nordisk: Levemir Revenue ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 6.6 Novo Nordisk: NovoMix Revenue ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 6.7 Eli Lilly: Humulin Revenue ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 6.8 Eli Lilly: Trulicity Revenue ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 6.9 Sanofi: Toujeo Revenue ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 6.10 Leading Pre-Filled Rheumatoid Arthritis Therapies: Revenues ($m), AGR (%) and CAGR (%), 2010-2015
  • Table 6.11 AbbVie/Eisai: Humira Revenue ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 6.12 Genentech/Biogen Idec: Rituxan Revenue ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 6.13 Amgen/Pfizer: Enbrel Revenue ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 6.14 Leading Pre-Filled Growth Hormone Therapies: Revenues ($m), AGR (%) and CAGR (%), 2014-2018
  • Table 6.15 Novo Nordisk: Norditropin Revenue ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 6.16 Pfizer: Genotropin Revenue ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 6.17 Sanofi: Praluent Revenue ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 6.18 Amgen: Repatha Revenue ($m), AGR (%) and CAGR (%), 2018-2029
  • Table 7.1 BD: Overview, 2017
  • Table 7.2 BD: Pre-Filled Injection Systems, 2017
  • Table 7.3 BD: Pharmaceutical Systems Revenue ($m), AGR (%), CAGR (%), 2012-2017
  • Table 7.4 Gerresheimer: Overview, 2017
  • Table 7.5 Gerresheimer: Pre-Filled Injection Systems, 2017
  • Table 7.6 Gerresheimer: Plastics & Devices and Primary Packaging Glass Segment Revenue ($m) 2015-2017, AGR (%)
  • Table 7.7 Schott: Overview, 2017
  • Table 7.8 Schott: Pre-Filled Injection Systems, 2017
  • Table 7.9 Schott: Net Revenue ($m), AGR (%) and CAGR (%), 2012-2017
  • Table 7.10 Unilife: Pre-Filled Syringe Product Portfolio, 2017
  • Table 7.11 Unilife: Net Revenue ($m), AGR (%) and CAGR (%), 2010-2016
  • Table 7.12 SHL Group: Overview, 2017
  • Table 7.13 SHL Group: Pen Injector and Autoinjector Portfolio, 2017
  • Table 7.14 Ypsomed: Overview, 2017
  • Table 7.15 Ypsomed: Pen Injector and Autoinjector Portfolio, 2017
  • Table 7.16 Ypsomed: Delivery Devices Revenue ($m), AGR (%) and CAGR (%), 2012-2017
  • Table 7.17 Haselmeier: Overview, 2017
  • Table 7.18 Haselmeier: Pen Injector and Autoinjector Portfolio, 2017
  • Table 7.19 Owen Mumford: Overview, 2017
  • Table 7.20 Owen Mumford: Pen Injector and Autoinjector Portfolio, 2017
  • Table 7.21 Datwyler: Overview, 2017
  • Table 7.22 Datwyler: Pharma Packaging Revenue ($m), AGR (%) and CAGR (%), 2012-2017
  • Table 8.1 Benefits and Weaknesses to Pre-Filled Syringes as an Injectable Delivery Device, 2018
  • Table 8.2 Pre-Filled Syringes Market: STEP Analysis, 2019-2029
  • Table 8.3 Selected Safety Products for Pre-Filled Syringes, 2018
  • Table 8.4 Selected Pre-Filled Injection Devices for Lyophilised Drugs, 2018
  • Table 8.5 Pre-Filled Syringe Manufacturers: Alternative Injectable Technologies, 2018
  • Table 8.6 Selected Insulin Pumps Available, 2018
  • Table 8.7 Oral Drug Competitors for Leading Pre-Filled Syringe Therapeutic Sectors, 2018-2029
  • Table 8.8 Selected Leading CMOs: Pre-Filled Syringe Filling Capabilities, 2018

List of Figures

  • Figure 1.1 Global Pre-Filled Syringes Market Segmentation Overview, 2017
  • Figure 2.1 Diagram of Syringe Parts
  • Figure 2.2 Timeline of Pre-Filled Syringe Development
  • Figure 2.3 Major Trends for Pre-Filled Syringe Market Growth, 2017
  • Figure 3.1 World Pre-Filled Syringes Market: Market Shares (%) by Segment, 2018
  • Figure 3.2 World Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2018-2029
  • Figure 3.3 World Pre-Filled Syringes Market by Revenue: Market Shares (%) by Segment, 2018
  • Figure 3.4 World Pre-Filled Syringes Market by Revenue: Market Shares (%) by Segment, 2023
  • Figure 3.5 World Pre-Filled Syringes Market by Revenue: Market Shares (%) by Segment, 2029
  • Figure 3.6 World Pre-Filled Syringes Market: Drivers and Restraints, 2018-2029
  • Figure 3.7 Glass Pre-Filled Syringes Market Forecast: Revenues ($m), 2018-2029
  • Figure 3.8 Glass Pre-Filled Syringes Market: Drivers and Restraints, 2018-2029
  • Figure 3.9 Plastic Pre-Filled Syringes Market Forecast: Revenues ($m), 2018-2029
  • Figure 3.10 Plastic Pre-Filled Syringes Market: Drivers and Restraints, 2018-2029
  • Figure 3.11 Pen Injectors and Autoinjectors Market Forecast: Revenues ($m) and AGR (%), 2018-2029
  • Figure 3.12 Pen Injectors and Autoinjectors Market: Drivers and Restraints, 2018-2029
  • Figure 4.1 World Pre-Filled Syringes Market: Revenues ($m) by National Market, 2018
  • Figure 4.2 World Pre-Filled Syringes Market: Market Shares (%) by National Market, 2018
  • Figure 4.3 World Pre-Filled Syringes Market: Market Shares (%) by National Market, 2023
  • Figure 4.4 World Pre-Filled Syringes Market: Market Shares (%) by National Market, 2029
  • Figure 4.5 World Pre-Filled Syringes Market: Revenues ($m) by Regional Market, 2018
  • Figure 4.6 World Pre-Filled Syringes Market: Market Shares (%) by Regional Market, 2018
  • Figure 4.7 World Pre-Filled Syringes Market: Market Shares (%) by Regional Market, 2023
  • Figure 4.8 World Pre-Filled Syringes Market: Market Shares (%) by Regional Market, 2029
  • Figure 4.9 U.S. Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2018-2029
  • Figure 4.10 U.S. Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Figure 4.11 U.S. Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Figure 4.12 Japanese Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2018-2029
  • Figure 4.13 Japanese Pre-Filled Syringes Market Forecast by Type: Revenues ($m) and AGR (%), 2018-2029
  • Figure 4.14 Japanese Pre-Filled Syringes Market Forecast by Application: Revenues ($m) and AGR (%), 2018-2029
  • Figure 4.15 EU5 Pre-Filled Syringes Market Forecast: Revenues ($m) by National Market, 2018-2029
  • Figure 4.16 UK Pre-Filled Syringes Market Forecast by Type: Revenues ($m), 2018-2029
  • Figure 4.17 UK Pre-Filled Syringes Market Forecast by Application: Revenues ($m), 2018-2029
  • Figure 4.18 Germany Pre-Filled Syringes Market Forecast by Type: Revenues ($m), 2018-2029
  • Figure 4.19 Germany Pre-Filled Syringes Market Forecast by Application: Revenues ($m), 2018-2029
  • Figure 4.20 France Pre-Filled Syringes Market Forecast by Type: Revenues ($m), 2018-2029
  • Figure 4.21 France Pre-Filled Syringes Market Forecast by Application: Revenues ($m), 2018-2029
  • Figure 4.22 Italy Pre-Filled Syringes Market Forecast by Type: Revenues ($m), 2018-2029
  • Figure 4.23 Italy Pre-Filled Syringes Market Forecast by Application: Revenues ($m), 2018-2029
  • Figure 4.24 Spain Pre-Filled Syringes Market Forecast by Type: Revenues ($m, 2018-2029
  • Figure 4.25 Spain Pre-Filled Syringes Market Forecast by Application: Revenues ($m), 2018-2029
  • Figure 4.26 Chinese Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2018-2029
  • Figure 4.27 Chinese Pre-Filled Syringes Market Forecast by Type: Revenues ($m) and AGR (%), 2018-2029
  • Figure 4.28 Chinese Pre-Filled Syringes Market Forecast by Application: Revenues ($m) and AGR (%), 2018-2029
  • Figure 4.29 Indian Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2018-2029
  • Figure 4.30 Indian Pre-Filled Syringes Market Forecast by Type: Revenues ($m) and AGR (%), 2018-2029
  • Figure 4.31 Indian Pre-Filled Syringes Market Forecast by Application: Revenues ($m) and AGR (%), 2018-2029
  • Figure 4.32 Russian Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2018-2029
  • Figure 4.33 Russian Pre-Filled Syringes Market Forecast by Type: Revenues ($m) and AGR (%), 2018-2029
  • Figure 4.34 Russian Pre-Filled Syringes Market Forecast by Application: Revenues ($m) and AGR (%), 2018-2029
  • Figure 4.35 Brazilian Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2018-2029
  • Figure 4.36 Brazilian Pre-Filled Syringes Market Forecast by Type: Revenues ($m) and AGR (%), 2018-2029
  • Figure 4.37 Brazilian Pre-Filled Syringes Market Forecast by Application: Revenues ($m) and AGR (%), 2018-2029
  • Figure 5.1 Insulin Market Forecast: Revenues ($m) and AGR (%), 2018-2029
  • Figure 5.2 Prefilled Syringes Application in Diabetes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Figure 5.3 Rheumatoid Arthritis Market Forecast: Revenues ($m) and AGR (%), 2018-2029
  • Figure 5.4 Prefilled Syringes Application in Rheumatoid Arthritis Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Figure 5.5 Growth Hormones Market Forecast: Revenues ($m) and AGR (%), 2018-2029
  • Figure 5.6 Vaccines Market Forecast: Revenues ($m) and AGR (%), 2018-2029
  • Figure 5.7 PCSK9 Inhibitors Market Forecast: Revenues ($m) and AGR (%), 2018-2029
  • Figure 5.8 Prefilled Syringes Application in Anaphylaxis Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
  • Figure 6.1 Sanofi: Lantus Revenue ($m) and AGR (%), 2018-2029
  • Figure 6.2 Novo Nordisk: NovoLog Revenue ($m) and AGR (%), 2018-2029
  • Figure 6.3 Eli Lilly: Humalog Revenue ($m) and AGR (%), 2018-2029
  • Figure 6.4 Novo Nordisk: Levemir Revenue ($m) and AGR (%), 2018-2029
  • Figure 6.5 Novo Nordisk: NovoMix Revenue ($m) and AGR (%), 2018-2029
  • Figure 6.6 Eli Lilly: Humulin Revenue ($m) and AGR (%), 2018-2029
  • Figure 6.7 Eli Lilly: Trulicity Revenue ($m) and AGR (%), 2018-2029
  • Figure 6.8 Sanofi: Toujeo Revenue ($m) and AGR (%), 2018-2029
  • Figure 6.9 AbbVie/Eisai: Humira Revenue ($m) and AGR (%), 2018-2029
  • Figure 6.10 Genentech/Biogen Idec: Rituxan Revenue ($m) and AGR (%), 2018-2029
  • Figure 6.11 Amgen/Pfizer: Enbrel Revenue ($m) and AGR (%), 2018-2029
  • Figure 6.12 Novo Nordisk: Norditropin Revenue ($m) and AGR (%), 2018-2029
  • Figure 6.13 Pfizer: Genotropin Revenue ($m) and AGR (%), 2018-2029
  • Figure 6.14 Sanofi/Regeneron: Praluent Revenue ($m) and AGR (%), 2018-2029
  • Figure 6.15 Amgen: Repatha Revenue ($m) and AGR (%), 2018-2029
  • Figure 7.1 Global Pre-filled syringes market market share in 2017
  • Figure 7.2 BD: Pharmaceutical Systems Revenue ($m), AGR (%), 2012-2017
  • Figure 7.3 Gerresheimer: Plastics & Devices and Primary Packaging Glass Segment Revenue ($m) 2015-2017, AGR (%)
  • Figure 7.4 Schott: Net Revenue ($m) and AGR (%), 2012-2017
  • Figure 7.5 Unilife: Net Revenue ($m) and AGR (%), 2010-2016
  • Figure 7.6 Ypsomed: Delivery Devices Revenue ($m) and AGR (%), 2012-2017
  • Figure 7.7 Datwyler: Pharma Packaging Revenue ($m) and AGR (%), 2012-2017
  • Figure 8.1 Pre-Filled Syringes Market: Strengths and Weaknesses, 2019-2029
  • Figure 8.2 Pre-Filled Syringes Market: Opportunities and Threats, 2017-2027
  • Figure 9.1 World Pre-Filled Syringes Market Forecast: Revenues ($m) by Segment, 2018-2029
Back to Top